Despite the evidence importance of this finding for T1D treatment, it should be noted that local immunosuppression achieved through CXCL12 has also been observed in cancer models where this mechanism protects cancer cells from immune attack (19). Here, CXCL12 is linked to type 1 diabetes mellitus.